FIELD: organic chemistry, chemical technology, pharmacy. SUBSTANCE: invention describes the novel derivatives of amino(thio)esters of the formula (I) where X means oxygen, sulfur atom and if R0 and R1 in common are not alkylene chain with 1-3 carbon atoms then CH2; Z means being n1 = 0, 1, 2 or 3; n2 = 0 or 1; n3 = 0, 1, 2 or 3 at condition that n1+n2+n3 <4; R0 means hydrogen atom or A; R1 means hydrogen atom, A, OA, phenoxy-group, Ph, OH, F, Cl, Br, CN, CF3, COOH, COOA, acyloxy-group with 1-4 carbon atoms, carboxamido-group; or R0 and R1 in common are alkylene chain with 1-3 carbon atoms or alkylene chain with 2-3 carbon atoms; R2 means hydrogen atom, A, Ac or -CH2-R4; R3 means CH2-R4 or CHA-R4 means Ph, 2-, 3- or 4-pyridyl that can be unsubstituted or monosubstituted with R4, unsubstituted thiophene or mono- or disubstituted thiophene with A, OA, OH, F, Cl, Br or other thienyl-group; R5 means phenyl group that can be unsubstituted or mono-, di-, tri-, tetra- or penta-substituted with F, R5, partially or totally fluorinated A, A and/or OA; CF3 each means independently and/or R6, R7, R8, R9 and R1 in common mean alkylene chain with 3-4 carbon atoms; A means alkyl with 1-6 carbon atoms; Ph means unsubstituted phenyl or phenyl substituted with R6, 2-, 3- or 4-pyridyl or phenoxyl-group. Invention relates to physiologically acceptable salts of these derivatives. New compounds effect on central nervous system, especially, as agonists and antagonists of serotonine. They can be used as active components of tranquilizers, antidepressants, neuroleptics and/or hypotensive agents. Invention describes also method of synthesis of compounds of the formula (I) R5, pharmaceutical composition based on said and method of composition preparing. EFFECT: new compounds indicated above, valuable pharmacological properties. 9 cl, 1 tbl, 28 ex
Authors
Dates
2000-09-10—Published
1995-10-13—Filed